BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $7,000 | +16.7% | 5,903 | -7.2% | 0.00% | – |
Q3 2019 | $6,000 | +50.0% | 6,360 | +295.0% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 1,610 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | 0.0% | 1,610 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -54.5% | 1,610 | 0.0% | 0.00% | – |
Q3 2018 | $11,000 | +120.0% | 1,610 | +163.9% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 610 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | +25.0% | 610 | +19.6% | 0.00% | – |
Q4 2017 | $4,000 | -42.9% | 510 | -14.4% | 0.00% | – |
Q3 2017 | $7,000 | +16.7% | 596 | +20.2% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 496 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | -33.3% | 496 | -9.0% | 0.00% | – |
Q4 2016 | $9,000 | -18.2% | 545 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | +120.0% | 545 | +32.9% | 0.00% | – |
Q2 2016 | $5,000 | +25.0% | 410 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | – | 410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |